Skip to main content
. 2013 Jul 16;45(18):834–855. doi: 10.1152/physiolgenomics.00092.2013

Table 3.

Analyses of Itpr3 WT and KO mice two-bottle choice test preference scores

Two-way ANOVA
Compound Cohort and Order Group Composition Group Concentration Group × Concentration Concentrations Supporting Strain Differences
Saccharin 5b 9 WT, 8 KO (M) F(1,15) = 23.5, P = 0.0002 F(6,90) = 5.09, P = 0.0002 F(6,90) = 2.97, P = 0.0108 1, 3.2, 10, 32 mM
Sucrose 1b 11 WT, 11 KO (F) F(1,20) = 15.7, P = 0.0007 F(7,140) = 45.9, P < 0.0001 F(7,140) = 3.50, P = 0.0017 1, 2, 4%
Maltose 4b 8 WT, 8 KO (F) F(1,14) = 23.8, P = 0.0002 F(7,98) = 29.2, P < 0.0001 F(7,98) = 3.92, P = 0.0008 1, 2, 4, 8%
Polycose 3b 9 WT, 9 KO (M) F(1,16) = 16.6, P = 0.0008 F(7,112) = 27.6, P < 0.0001 F(7,112) = 4.66, P = 0.0001 0.5, 1, 2, 4, 20%
MSG 6a, 8a 18 WT, 16 KO (F) F(1,32) = 2.33, P = 0.1368 F(6,192) = 32.70, P < 0.0001 F(6,192) = 1.75, P = 0.1117 10, 32 mM*
IMP 6b 9 WT, 8 KO (F) F(1,15) = 2.69, P = 0.1214 F(8,120) = 16.4, P < 0.0001 F(8,120) = 3.10, P = 0.0033 10, 32 mM
Na3HP2O7 7a 8 WT, 8 KO (M) F(1,14) = 19.9, P = 0.0008 F(10,140) = 23.2, P < 0.0001 F(10,140) = 6.05, P < 0.0001 5.6, 10, 18, 32, 56 mM
HCl 2c 9 WT, 10 KO (M) F(1,17) = 353.6, P < 0.0001 F(5,85)= 10.7, P < 0.0001 F(5,85) = 1.16, P = 0.3360 none
Citric acid 1d 11 WT, 11 KO (F) F(1,19) = 4.33, P = 0.0512 F(5,95) = 18.0, P < 0.0001 F(5,95) = 0.63, P = 0.6744 none
Denatonium 1c, 7d 8 WT, 9 KO(M) 11 WT, 10 KO (F) F(1,36) = 14.6, P = 0.0005 F(6,216) = 21.7, P < 0.0001 F(6,216) = 3.98, P = 0.0009 0.032, 0.1, 0.32, 1 mM
QHCl 2b 9 WT, 10 KO (M) F(1,17) = 34.6, P < 0.0001 F(3,51) = 3.62, P = 0.0191 F(3,51) = 1.33, P = 0.2760 all*
Caffeine 3c 9 WT, 9 KO (M) F(1,16) = 0.79, P = 0.3859 F(4,64) = 27.0, P < 0.0001 F(4,64) = 2.18, P = 0.0815 none
ZnCl2 7c 8 WT, 9 KO (F) F(1,15) = 9.68, P = 0.0071 F(4,60) = 49.8, P < 0.0001 F(4,60) = 4.05, P = 0.0057 3.2, 10, 32 mM
Capsaicin 2d 9 WT, 10 KO (M) F(1,17) = 5.77, P = 0.0280 F(4,68) = 22.0, P < 0.0001 F(4,68) = 0.80, P = 0.5280 none
CaCl2 1a 11 WT, 11 KO (F) F(1,20) = 59.3, P < 0.0001 F(4,80) = 18.6, P < 0.0001 F(4,80) = 10.3, P < 0.0001 10, 32, 100 mM
CaLa 2a 9 WT, 10 KO (M) F(1,17) = 53.6, P < 0.0002 F(4,68) = 1.46, P = 0.2233 F(4,68) = 3.81, P = 0.0075 1,3.2, 10, 32, 100 mM
MgCl2 3a, 8a 18 WT, 18 KO (M) F(1,34)= 23.2, P < 0.0001 F(4,136) = 10.9, P < 0.0001 F(4,136) = 1.27, P = 0.2861 10, 32 mM*
NaCl 4a 8 WT, 8 KO (F) F(1,14) = 0.58, P = 0.4569 F(5,70) = 22.8, P < 0.0001 F(5,70) = 0.61, P = 0.6922 none
NaLa 5a 9 WT, 8 KO (M) F(1,15) = 0.70, P = 0.4150 F(5,75) = 25.4, P < 0.0001 F(5,75) = 1.20, P = 0.3162 none
KCl 4d, 5c 9 WT, 8 KO (M) F(1,31) = 7.95, P = 0.0083 F(4,124) = 18.1, P < 0.0001 F(4,124) = 3.03, P = 0.0201 100, 178 mM
8 WT, 8 KO (F)
NH4Cl 3d, 7b, 8b 17 WT, 17 KO (M) F(1,48) = 6.55, P = 0.0137 F(5,240) = 26.9, P < 0.0001 F(5,240) = 2.85, P = 0.0162 3.2, 32, 100 mM
9 WT, 9 KO (F)

Compounds are listed in the order presented in Figs. 35. Cohort and order provides batch of mice (1–8) and compounds tested in alphabetical order (a–d), with “a” being tested first, “b” second, and so on. Group composition gives number of wild-type (WT) and knockout (KO) mice tested; each cohort was either all M or all F. Concentrations supporting strain differences = P < 0.05 according to post hoc Fisher LSD tests.

*

Post hoc tests not strictly justified given the nonsignificant interaction (although a significant main effect of group). The analysis of KCl preferences omitted results of the test with 562 mM KCl because 18 of 33 mice spilled this concentration.